Advertisement
Canada markets close in 2 hours 4 minutes
  • S&P/TSX

    21,838.44
    +130.00 (+0.60%)
     
  • S&P 500

    4,993.92
    -17.20 (-0.34%)
     
  • DOW

    38,069.73
    +294.35 (+0.78%)
     
  • CAD/USD

    0.7278
    +0.0014 (+0.20%)
     
  • CRUDE OIL

    83.54
    +0.81 (+0.98%)
     
  • Bitcoin CAD

    88,963.09
    +2,671.64 (+3.10%)
     
  • CMC Crypto 200

    1,380.51
    +67.89 (+5.17%)
     
  • GOLD FUTURES

    2,410.60
    +12.60 (+0.53%)
     
  • RUSSELL 2000

    1,943.78
    +0.82 (+0.04%)
     
  • 10-Yr Bond

    4.6290
    -0.0180 (-0.39%)
     
  • NASDAQ

    15,410.17
    -191.33 (-1.23%)
     
  • VOLATILITY

    18.65
    +0.65 (+3.61%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6827
    +0.0006 (+0.09%)
     

LAWSUITS FILED AGAINST GTX, ICPT and BABA - Jakubowitz Law Pursues Shareholders Claims

NEW YORK, NY / ACCESSWIRE / November 23, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

Garrett Motion Inc. (NYSE:GTX)

CONTACT JAKUBOWITZ ABOUT GTX:
https://claimyourloss.com/securities/garrett-motion-inc-loss-submission-form/?id=11126&from=1

Class Period : October 1, 2018 - September 18, 2020

Lead Plaintiff Deadline : November 24, 2020

ADVERTISEMENT

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) due to its agreement to indemnify and reimburse Honeywell for certain asbestos-related liability, Garrett was saddled with an unsustainable level of debt; (2) as a result, Garrett had a highly leveraged capital structure that posed significant challenges to its overall strategic and financial flexibility; (3) as a result of the foregoing, Garrett's ability to gain or hold market share was impaired; (4) as a result of the foregoing, the Company was reasonably likely to seek bankruptcy protection; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)

CONTACT JAKUBOWITZ ABOUT ICPT:
https://claimyourloss.com/securities/intercept-pharmaceuticals-inc-loss-submission-form/?id=11126&from=1

Class Period : September 28, 2019 - October 7, 2020

Lead Plaintiff Deadline : January 4, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Defendants downplayed the true scope and severity of safety concerns associated with the use of Ocaliva (obeticholic acid ("OCA")), Intercept's lead product candidate, in treating primary biliary cholangitis; (ii) the foregoing increased the likelihood of a U.S. Food and Drug Administration ("FDA") investigation into Ocaliva's development, thereby jeopardizing Ocaliva's continued marketability and the sustainability of its sales; (iii) any purported benefits associated with OCA's efficacy in treating nonalcoholic steatohepatitis ("NASH") were outweighed by the risks of its use; (iv) as a result, the FDA was unlikely to approve the Company's New Drug Application for OCA in treating patients with liver fibrosis due to NASH; and (v) as a result of all the foregoing, the Company's public statements were materially false and misleading at all relevant times.

Alibaba Group Holding Limited (NYSE:BABA)

CONTACT JAKUBOWITZ ABOUT BABA:
https://claimyourloss.com/securities/alibaba-group-holding-limited-loss-submission-form/?id=11126&from=1

Class Period : October 21, 2020 - November 3, 2020

Lead Plaintiff Deadline : January 12, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Ant Small and Micro Financial Services Group Co., Ltd. ("Ant Group"), a financial technology company in which Alibaba owns a 33% equity interest, did not meet listing qualifications or disclosure requirements for certain material matters; (2) certain impending changes in the Fintech regulatory environment would impact Ant Group's business; (3) as a result of the foregoing, Ant Group's initial public offering was reasonably likely to be suspended; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

SOURCE: Jakubowitz Law



View source version on accesswire.com:
https://www.accesswire.com/617922/LAWSUITS-FILED-AGAINST-GTX-ICPT-and-BABA--Jakubowitz-Law-Pursues-Shareholders-Claims